Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-06

Clinical Trial Update: Adaptive, Real-time, Intelligent System to Enhance Self-care of Chronic Disease [NA]

View source ↗

Summary

A completed clinical trial from Imperial College London evaluating an adaptive, real-time system to enhance self-care for Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2020-08-06